Skip to main content
    E

    Eocene Ltd. (EOCN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.24
    -0.24 (-9.68%)

    Market Cap: $2.65M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Eocene Ltd. (EOCN) Financials: Revenue, Profit and Cash Flow

    Updated Aug 31, 2026. Financial statements from company filings, amounts in US dollars.

    Eocene reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$10.31M, operating cash flow was -$6.32M and free cash flow was -$6.32M. The quarter ended Jun 30, 2026 had revenue of $0 and net income of -$2.72M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $8.51M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2022 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Research and development$4.87M$2.98M$3.57M$12.99M
    Operating income-$8.51M-$6.28M-$7.49M-$17.65M
    Net income-$10.31M-$7.52M-$6.91M-$17.87M
    EBITDA-$8.51M-$6.20M-$7.46M-$17.62M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025
    Operating income-$2.77M-$2.04M-$3.04M-$2.10M-$2.11M
    Net income-$2.72M-$1.91M-$4.82M-$1.89M-$2.50M
    Last 5 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $3.98M were 21.4% of total assets of $18.63M, against total liabilities of $2.85M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Total assets$18.63M$18.50M$16.63M$16.56M
    Current assets$18.63M$16.12M$13.24M$14.72M
    Cash and equivalents$3.98M$4.65M$2.86M$2.02M
    Total liabilities$2.85M$2.17M$2.75M$3.14M
    Shareholder equity$15.78M$16.33M$13.88M$13.42M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025
    Total assets$18.28M$16.03M$18.63M$21.58M$22.94M
    Total liabilities$5.54M$2.08M$2.85M$2.47M$2.42M
    Cash and equivalents$2.88M$1.60M$3.98M$3.31M$4.96M
    Shareholder equity$12.74M$13.95M$15.78M$19.11M$20.52M
    Last 5 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Operating cash flow-$6.32M-$5.88M-$6.14M-$18.50M
    Capital expenditures$0$0$0$4.00K
    Free cash flow-$6.32M-$5.88M-$6.14M-$18.50M
    Financing cash flow$9.03M$8.79M$6.18M$70.00K
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025
    Operating cash flow-$2.13M-$2.54M-$1.95M-$1.94M-$1.27M
    Free cash flow-$2.13M-$2.54M-$1.95M-$1.94M-$1.27M
    Last 5 quarters

    Frequently Asked Questions About EOCN

    What is Eocene's annual revenue?

    Eocene reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Eocene profitable?

    No. Eocene reported net income of -$10.31M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does EOCN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$6.32M minus capital expenditures of $0 produced free cash flow of -$6.32M.

    How much debt does Eocene have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $3.98M.